Ozempic Increase Is an Alternative for Well being Insurers

You’d suppose a brand new class of high-price weight reduction medication taken by hundreds of thousands of Individuals can be an issue for well being insurers. In spite of everything, they in the end foot the invoice. However it’s extra sophisticated than that: Some insurance coverage giants truly stand to revenue from the Ozempic craze.

The business has been calling out the prices of GLP-1 medication, that are used for each diabetes and weight problems. However federally supported Medicare and Medicaid nonetheless don’t cowl the medication for weight problems, and far of the industrial market is self-insured. In different phrases, although your insurance coverage card says “Aetna” or “UnitedHealthcare,” these firms in some instances solely act as directors. Meaning employers are those bearing the threat of runaway prices.